Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MultiCell fulfills license fee for MS drug
The payment was completed pursuant to the terms of the amended license agreement with Amarin Neuroscience. MultiCell estimates MCT-125 could generate up to $3 billion in cumulative worldwide
The payment was completed pursuant to the terms of the amended license agreement with Amarin Neuroscience. MultiCell estimates MCT-125 could generate up to $3 billion in cumulative worldwide
The study was led by researchers at Beth Israel Deaconess Medical Center (BIDMC), in collaboration with scientists at Columbia University Medical Center. In cases of chronic inflammation, certain
“We want to ensure that our application to the FDA is as robust as possible in an evolving regulatory environment and we are confident that the additional data
“This approval is another example of our agency’s efforts to increase access to safe and effective generic alternatives as soon as the law permits,” said Gary Buehler, director,
This appeal is in response to the Office of New Drugs denial in August 2006 of Epix’s appeal of two approvable letters. The decision to appeal was made
A study revealed that particpants who received Arimidex and Herceptin in combination demonstrated an extended median progression-free survival of 4.8 months, representing an extension of 2.4 months over
The preliminary injunction was requested by Novo Nordisk as part of a patent infringement case that will be heard by the same court. Novo Nordisk had sued Pfizer
Following the redundancies, Adolor’s headcount will stand at 128, down from 180. The company expects to take a one time charge of approximately $2-3 million in the fourth
As a result of the acquisition, Forest will obtain development and marketing rights worldwide excluding Japan for two antibiotics, Ceftaroline and ME1036. Ceftaroline will enter phase III trials
Under the terms of the deal, Sinclair will supply Aloclair Spray to Omni Preventive Care, which will be responsible for the marketing and distribution of the product in